VP/ED, Head of Scientific Evaluation & Prioritization, ...

SummaryThis unique opportunity lets you harness your scientific and clinical research expertise to drive strategic research portfolio decisions that will shape this leading global biopharmas research pipeline across multiple major therapeutic areas, modalities, and mechanisms of action. You will drive data-driven compound prioritization decisions to maximize clinical advancement potential and optimize capital allocation (i.e., drive desired outcomes to advance more prioritized compounds into the clinic/to INDs).This innovative biopharma leader has built sophisticated in-house capabilities that mirror those of major healthcare investment firms, providing the talent/human capital and analytical resources needed to drive deep scientific, clinical, and commercial evaluations to make data-driven strategic research portfolio decisions for maximum potential progress/impact.This highly visible and critical strategic scientific leadership position will be a good fit for candidates with a proven track record of evaluating and selecting various/varying multiple research portfolio compounds for prioritization that have led to multiple compounds advancing into the clinic/INDs. (Important note: This is not a Program Management, Portfolio Management, Business Development/BD, or Search and Evaluation position)Attractive Features Include-Unique Role: create 1st set of footprints for this newly created scientific strategy & evaluation role-Influence: drive deep scientific evaluation & key decisions that will reshape the research portfolio-Impact: drive strategic compound prioritization & deprioritization decisions-Results: key role that will help generate portfolio outcomes: advancing compounds to INDs/clinic-Deep science: harness the depth of your scientific expertise to evaluate many compounds-Innovative: utilize a pioneering approach: utilize in-house capabilities built to mirror those of a specialized/dedicated multi-billion healthcare investment firm-Visibility: directly interact and collaborate with C-level & multi-functional leaders (research, development, commercial and others)-Significant Capital: significantly influence & impact capital deployment of (~$1 Billion) decisionsLocation: Boston, MAHybrid Role: Onsite 3 days per weekRelocation Assistance is available for qualified candidatesQualifications-PhD-Proven track record of evaluating and selecting multiple compounds that successfully progressed from research into the clinic/to INDs-Deep scientific expertise in evaluating compounds across therapeutic areas, modalities, and mechanisms of action-Experience working effectively across research, development, and commercial operations-Ability to influence and challenge senior leaders respectfullyConfidentiality: All communications and information shared are confidential.ContactCliff Miras | Managing PartnerMiras Search PartnersSpecialized Executive Search & RecruitmentPharmaceutical & Biotechnology Industry SpecialistsE: cliff@P: 212-970-0550 (NYC Area) | P: 617-993-9777 (Boston Area) |W: About Miras Search PartnersMiras Search Partners is a boutique specialty pharmaceutical and biotechnology executive search and recruitment firm with over 20 years of expertise in these sectors. We help pharmaceutical and biotechnology companies of all commercial sizes (i.e., large, mid-sized, and small) and at varying stages of research & discovery and clinical development to find, attract, and hire the talent they need to prosper.KeywordsChief Scientific Officer, CSO, Head, Leader, drug discovery, drug development, preclinical, translational, IND, IND-enabling, therapeutic areas, strategy, innovation, portfolio, prioritization, prioritize, deprioritize, optimization, pharmaceutical, biopharmaceutical, biotechnology, life sciences, healthcare, firm, investment, venture, novel, targets, first-in-class, breakthrough, biologics, small molecules, Ph.D., doctorate, first-in-human, FIH, clinic

Created: 2025-02-25